Heart patients in U.S. find vital new drugs not approved for sale.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000319:Adrenergic beta-Antagonists; D011433:Propranolol